Solvay will present at MD&M West 2019 on the use of metal-to-plastic conversion to drive new medical device designs. Solvay’s Global Market Manager for Healthcare, Anna Maria Bertasa, will present the paper on Thursday, Feb. 7, from 10:30 – 11:00 a.m. Pacific Standard Time (PST). Titled, “How to Make Specialty Polymers as Strong as Metal,” Bertasa will discuss how specialty polymers can be used to replace even the strongest and stiffest steel devices by incorporating simple design modifications, and how advanced polymers are now being used to enable innovative hybrid polymer-metal solutions. Her presentation will include case studies to illustrate typical development cycles and highlight the performance advantages that can be achieved by replacing metal with polymer technologies to create next-generation devices.
Solvay will also spotlight a range of new and legacy high-performance polymers and applications at its booth. These include disinfectant-resistant polymers like Kalix® high-performance polyamides (HPPA) for medical equipment housings, electrosurgical instruments coated with its KetaSpire® polyetheretherketone (PEEK), and hybrid surgical instrument sterilization trays made using Radel® polyphenylsulfone (PPSU). Other advanced materials will also be featured, showcasing how Solvay’s broad portfolio gives healthcare OEMs wide-ranging combinations of chemical, thermal, and mechanical properties, along with superior surface aesthetics, excellent electrical properties and UL 94 V-0 flame retardancy.
Solvay is an advanced material and specialty chemicals company, committed to developing the chemistry that addresses key societal challenges. Solvay innovates and partners with customers worldwide in many diverse end markets. Its products are used in planes, cars, batteries, smart and medical devices, as well as in mineral and oil and gas extraction, enhancing efficiency and sustainability. Its lightweight materials promote cleaner mobility, its formulations optimize the use of resources and its performance chemicals improve air and water quality. Solvay is headquartered in Brussels with around 26,800 employees in 61 countries. Net sales were €10.1 billion in 2017, with 90% from activities where Solvay ranks among the world’s top 3 leaders, resulting in an EBITDA margin of 22%. Solvay SA (SOLB.BE) is listed on Euronext Brussels and Paris (Bloomberg: SOLB.BB – Reuters: SOLB.BR) and in the United States its shares (SOLVY) are traded through a level-1 ADR program. Financial figures take into account the announced divestment of Polyamides.
Solvay Specialty Polymers manufactures over 1500 products across 35 brands of high-performance polymers – fluoropolymers, fluoroelastomers, fluorinated fluids, semi-aromatic polyamides, sulfone polymers, ultra-high-performance aromatic polymers, and high-barrier polymers – for use in Aerospace, Alternative Energy, Automotive, Healthcare, Membranes, Oil and Gas, Packaging, Plumbing, Semiconductors, Wire & Cable, and other industries. Learn
more at www.solvayspecialtypolymers.com.
® Kalix, Radel and KetaSpire are registered trademarks of Solvay
Solvay Specialty Polymers
+1 770 772 8451
AH&M Marketing Communications
+1 413 448 2260 Ext. 470
Solvay Specialty Polymers
+39 338 603 4561
Industrial Media Relations
+32 474 117 091
Courtesy of solvay.com
More reading: Solvay launches high-performance 3D printing materials